Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optima: a windows-based program for computer-aided optimization of controlled-release dosage forms

D R Lu1, K Abu-Izza, W Chen

  • 1Department of Pharmaceutics, College of Pharmacy, University of Georgia, Athens 30602, USA. rlu@merc.rx.uga.edu

Pharmaceutical Development and Technology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109).

ESMO open·2025
Same author

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up.

Breast cancer research and treatment·2019
Same author

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Enhanced solubility and bioavailability of zanubrutinib nanocrystals: Physicochemical and Pharmacokinetic evaluation.

Pharmaceutical development and technology·2026
Same journal

Intradermal delivery of lidocaine hydrochloride using dissolving microneedles: <i>In vitro</i> dermatokinetic test and <i>in vivo</i> anesthetic activity assessment.

Pharmaceutical development and technology·2026
Same journal

Quality by design-guided development of silica-enabled lipid hybrid nanoparticles for enhanced olaparib dissolution.

Pharmaceutical development and technology·2026
Same journal

Surface engineering of nanocarriers with polymer coatings: materials, strategies, functional outcomes, and clinical translation.

Pharmaceutical development and technology·2026
Same journal

Compression equations in pharmaceutical tableting: from classical compaction models to data-driven and mechanistic approaches.

Pharmaceutical development and technology·2026
Same journal

Intranasal mucoadhesive biomaterials for nose-to-brain neuroactive delivery: platform design and model-informed translation for time-bounded CNS exposure.

Pharmaceutical development and technology·2026
See all related articles

A new computer program, Optima, aids in optimizing controlled-release drug delivery systems using response surface methodology (RSM). It successfully predicted optimal formulations for sustained-release microspheres, closely matching experimental results.

Area of Science:

  • Pharmaceutical Sciences
  • Computer Science
  • Chemical Engineering

Background:

  • Optimizing controlled-release drug delivery systems is crucial for therapeutic efficacy.
  • Existing methods for optimization can be complex and time-consuming.
  • A need exists for user-friendly, integrated software to streamline this process.

Purpose of the Study:

  • To develop a computer program, Optima, for visual and mathematical optimization of controlled-release devices.
  • To implement response surface methodology (RSM) within a user-friendly, graphical interface.
  • To validate the program's effectiveness in optimizing pharmaceutical dosage forms.

Main Methods:

  • Development of a Windows-based program, Optima, incorporating RSM and central composite design.

Related Experiment Videos

  • Implementation of subroutines for interactive optimization, including first- and second-order model fitting.
  • Utilizing linear and exponential desirability functions to create an overall desirability function for multi-response optimization.

    • Main Results:

    • Optima successfully optimized sustained-release AZT-loaded microspheres, predicting optimal variable levels with high accuracy.
    • The program generated response surfaces and predicted optimum levels, which closely matched observed experimental responses.
    • Observed responses for the optimized formulation were highly consistent with Optima's predictions.

    Conclusions:

    • Optima is a valuable, integrated tool for the optimization of controlled-release microspheres.
    • The program simplifies complex optimization procedures through a graphical and interactive interface.
    • Optima demonstrates significant utility in pharmaceutical formulation development and research.